Clinical Studies & Pharmacologic Profile
Indications
Naropin is indicated for the production of local or regional anesthesia for surgery and for acute pain management
- Surgical Anesthesia:
- Epidural block for surgery including cesarean section
- Major nerve block
- Local infiltration
- Acute pain management
- Epidural continuous infusion or intermittent bolus (postoperative or labor)
- Local infiltration
Naropin is contraindicated in patients with a known hypersensitivity to ropivacaine or to any local anesthetic agent of the amide type.
Click here for more information on:
 |
|
 |
 |
 |
 |
|
|
Important Safety Information
Using NAROPIN® beyond recommended doses to increase motor block or duration of sensory block may negate its favorable cardiovascular advantages, in the event that an inadvertent intravascular injection occurs.
Like all amide-type local anesthetics, NAROPIN® may be associated with adverse reactions. In clinical trials, side effects were mild and transient and may reflect the procedures, patient health status, and/or other medications used. Adverse events reported at a rate of ≥5%: hypotension, nausea, vomiting, bradycardia, fever, pain, postoperative complications, anemia, paresthesia, headache, pruritus, and back pain.
Using NAROPIN® beyond recommended doses to increase motor block or duration of sensory block may negate its favorable cardiovascular advantages, in the event that an inadvertent intravascular injection occurs.
Like all amide-type local anesthetics, NAROPIN® may be associated with adverse reactions. In clinical trials, side effects were mild and transient and may reflect the procedures, patient health status, and/or other medications used. Adverse events reported at a rate of ≥5%: hypotension, nausea, vomiting, bradycardia, fever, pain, postoperative complications, anemia, paresthesia, headache, pruritus, and back pain.